Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Systemic glucose metabolism and immune pathways represent a complex network of physiological processes rather than a single molecular target. This system encompasses the hormonal regulation of blood sugar levels and the activation of immune cells, which are intrinsically linked through the field of immunometabolism (Nature Reviews Immunology, 2017). In conditions like type 2 diabetes, chronic overnutrition leads to metabolic stress that triggers inflammatory pathways, while immune cells themselves require precise glucose regulation to function effectively during infection or injury (Cell Metabolism, 2016). Therapeutic intervention in this area typically involves targeting specific enzymes or receptors within these pathways, such as the insulin receptor or various cytokines, to restore homeostasis. Because the term describes a broad set of biological interactions and not a specific protein or gene product, it is classified as an incorrect target designation for drug discovery purposes.
Modulation of systemic energy balance and inflammatory signaling cascades to restore physiological homeostasis.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Systemic glucose metabolism and immune pathways.